Loading
Life sciences · Journal article
Acs Applied Polymer Materials · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract The integration of nanozyme-based catalytic activity interventions within the tumor microenvironment (TME) with phototherapies represents a promising approach for triggering multimodal synergistic cancer therapy. Herein, a protein-mineralized nanozyme was fabricated via in situ biomineralization, utilizing iron ions coordinated with glucose oxidase (GOx-Fe). Unlike traditional nanozyme systems that rely on passive targeting or a single catalytic function, the design uniquely integrates a cascade therapeutic system within a single biocompatible platform. This nanozyme possesses dual catalytic properties to facilitate glucose oxidation and the conversion of hydrogen peroxide (H2O2) into hydroxyl radicals (•OH) and oxygen (O2). This dual-catalytic mechanism establishes a self-augmenting cascade that concurrently activates starvation therapy (ST) and chemodynamic therapy (CDT) within a signal nanosystem. To achieve tumor-specific delivery, the GOx-Fe nanozyme was modified with a polymer consisting of Chlorin e6-functionalized PEGylated hyaluronic acid (mHDC). The resulting GOx-Fe@mHDC nanozyme exhibits a uniform spherical morphology with an average hydrodynamic diameter of approximately 50 nm and a negative surface charge of about −19 mV. It maintains stability across diverse physiological environments but undergoes activation in the enzyme-rich TME, ensuring targeted and selective therapeutic effects. The nanozyme demonstrates efficient glucose consumption (approaching the performance of free GOx) and significant intracellular H2O2 generation (290% higher than free GOx), leading to enhanced •OH production and O2 self-supply. In A549 tumor-bearing mice, intravenous administration of GOx-Fe@mHDC followed by 660 nm laser irradiation resulted in marked tumor growth inhibition (tumor weight suppression rate of 86%) with negligible systemic toxicity. Importantly, the developed GOx-Fe@mHDC system exhibited strong catalytic stability, targeted tumor accumulation, effective endolysosomal escape, selective cytotoxicity, and substantial in vivo tumor suppression with excellent biosafety. This research introduces a versatile biomineralization technique for constructing Fe-based nanozymes with dual catalytic and tumor-specific capabilities, offering a scalable approach for advancing cancer therapeutics.